Nordea Investment Management’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.09M	Sell	580,755 -28,971	-5%	-$231K	﹤0.01%	581
2025 Q4	$3.55M	Sell	609,726 -104,835	-15%	-$624K	﹤0.01%	659
2025 Q3	$3.93M	Buy	714,561 +10,184	+1%	+$52.1K	﹤0.01%	639
2025 Q2	$3.68M	Buy	704,377 +564,537	+404%	+$3.03M	﹤0.01%	619
2025 Q1	$891K	Buy	139,840 +3,353	+2%	+$29.8K	﹤0.01%	823
2024 Q4	$1M	Sell	136,487 -286,600	-68%	-$2.26M	﹤0.01%	806
2024 Q3	$3.24M	Buy	423,087 +147,552	+54%	+$1.28M	﹤0.01%	603
2024 Q2	$2.43M	Buy	275,535 +39,871	+17%	+$382K	﹤0.01%	664
2024 Q1	$2.41M	Buy	235,664 +87,190	+59%	+$888K	﹤0.01%	683
2023 Q4	$1.5M	Sell	148,474 -2,687	-2%	-$24.6K	﹤0.01%	747
2023 Q3	$1.42M	Sell	151,161 -1,516	-1%	-$21.6K	﹤0.01%	751
2023 Q2	$3.78M	Buy	152,677 +3,415	+2%	+$85.8K	0.01%	575
2023 Q1	$3.45M	Sell	149,262 -4,833	-3%	-$124K	0.01%	595
2022 Q4	$3.84M	Buy	154,095 +635	+0.4%	+$15.6K	0.01%	570
2022 Q3	$2.98M	Sell	153,460 -558	-0.4%	-$14.2K	﹤0.01%	620
2022 Q2	$3.91M	Buy	154,018 +2,483	+2%	+$58K	0.01%	587
2022 Q1	$3.99M	Buy	151,535 +2,510	+2%	+$74.4K	0.01%	621
2021 Q4	$6.21M	Buy	149,025 +139,722	+1,502%	+$5.47M	0.01%	541
2021 Q3	$414K	Buy	+9,303	New	+$403K	﹤0.01%	943